Glenn Sobotka - 07 Aug 2026 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Reporting relationship: Former Officer
Issuer ticker: ASTH
Reported as of: 07 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2026, 17:09:44 UTC
Prior SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathy Diep, as Attorney-in-Fact

Key filing fact

Glenn Sobotka filed Form 4 for Astrana Health, Inc. (ASTH) on 11 Aug 2026.

Key facts

This page summarizes Glenn Sobotka's Form 4 filing for Astrana Health, Inc. (ASTH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Aug 2026, 17:09.

Change

Previous filing in this sequence was filed on 30 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001855927 Primary reporting owner

Sobotka Glenn

Relationship: Former Officer
Address: C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA
Signature: /s/ Kathy Diep, as Attorney-in-Fact
Signature date: 11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -11,793
Change %: -84%
Price: $0.000000^*
Shares after: 2,246
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Glenn Sobotka is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Represents the surrender of unvested time-based and performance-based restricted stock that was forfeited in connection with the reporting person's retirement from his positions with the Issuer.

Footnote F2

Includes 1,300 shares of restricted stock that will vest on an accelerated basis in connection with the reporting person's retirement from his positions with the Issuer, subject to his execution of a release of claims.